| SNARE-mediated rapid lysosome fusion in membrane raft clustering and dysfunction of bovine coronary arterial endothelium. | |
| | |
MedLine Citation:
|
PMID: 21926345 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The present study attempted to evaluate whether soluble N-ethylmaleimide-sensitive factor attachment protein receptors (SNAREs) mediate lysosome fusion in response to death receptor activation and contribute to membrane raft (MR) clustering and consequent endothelial dysfunction in coronary arterial endothelial cells. By immunohistochemical analysis, vesicle-associated membrane proteins 2 (VAMP-2, vesicle-SNAREs) were found to be abundantly expressed in the endothelium of bovine coronary arteries. Direct lysosome fusion monitoring by N-(3-triethylammoniumpropyl)-4-[4-(dibutylamino)styryl]pyridinium dibromide (FM1-43) quenching demonstrated that the inhibition of VAMP-2 with tetanus toxin or specific small interfering ribonucleic acid (siRNA) almost completely blocked lysosome fusion to plasma membrane induced by Fas ligand (FasL), a well-known MR clustering stimulator. The involvement of SNAREs was further confirmed by an increased interaction of VAMP-2 with a target-SNARE protein syntaxin-4 after FasL stimulation in coimmunoprecipitation analysis. Also, the inhibition of VAMP-2 with tetanus toxin or VAMP-2 siRNA abolished FasL-induced MR clustering, its colocalization with a NADPH oxidase unit gp91(phox), and increased superoxide production. Finally, FasL-induced impairment of endothelium-dependent vasodilation was reversed by the treatment of bovine coronary arteries with tetanus toxin or VAMP-2 siRNA. VAMP-2 is critical to lysosome fusion in MR clustering, and this VAMP-2-mediated lysosome-MR signalosomes contribute to redox regulation of coronary endothelial function. |
| | |
Authors:
|
Wei-Qing Han; Min Xia; Chun Zhang; Fan Zhang; Ming Xu; Ning-Jun Li; Pin-Lan Li |
Related Documents
:
|
18436335 - The rsu-1-pinch1-ilk complex is regulated by ras activation in tumor cells. 19361585 - Rho gtpase signaling and pth 3-34, but not pth 1-34, maintain the actin cytoskeleton an... 18515405 - Critical role of cdc42 in mediating endothelial barrier protection in vivo. 18319625 - V-crk induces rac-dependent membrane ruffling and cell migration in cas-deficient embry... 17053325 - Culture of human skeletal muscle myoblasts: timing appearance and localization of dystr... 9711345 - Adhesion and co-stimulatory molecules in the pathogenesis of hepatic and intestinal sch... |
Publication Detail:
|
Type: Journal Article; Research Support, N.I.H., Extramural Date: 2011-09-16 |
Journal Detail:
|
Title: American journal of physiology. Heart and circulatory physiology Volume: 301 ISSN: 1522-1539 ISO Abbreviation: Am. J. Physiol. Heart Circ. Physiol. Publication Date: 2011 Nov |
Date Detail:
|
Created Date: 2011-11-04 Completed Date: 2011-12-23 Revised Date: 2013-05-23 |
Medline Journal Info:
|
Nlm Unique ID: 100901228 Medline TA: Am J Physiol Heart Circ Physiol Country: United States |
Other Details:
|
Languages: eng Pagination: H2028-37 Citation Subset: IM |
Affiliation:
|
Department of Pharmacology and Toxicology, Medical College of Virginia Campus, Virginia Commonwealth University, Richmond, VA 23298, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Animals Bradykinin / pharmacology Cattle Cells, Cultured Coronary Vessels / drug effects, metabolism*, physiopathology Dose-Response Relationship, Drug Endothelial Cells / drug effects, metabolism* Endothelium, Vascular / drug effects, metabolism*, physiopathology Fas Ligand Protein / metabolism Fluorescence Resonance Energy Transfer Immunohistochemistry Immunoprecipitation Lysosomal-Associated Membrane Protein 1 / metabolism Lysosomes / drug effects, metabolism* Membrane Fusion* / drug effects Membrane Microdomains / drug effects, metabolism* Microscopy, Confocal NADPH Oxidase / metabolism Protein Transport Qa-SNARE Proteins / metabolism RNA Interference Superoxides / metabolism Tetanus Toxin / pharmacology Time Factors Vasodilation* / drug effects Vasodilator Agents / pharmacology Vesicle-Associated Membrane Protein 2 / antagonists & inhibitors, genetics, metabolism* |
| Grant Support | |
ID/Acronym/Agency:
|
HL-091464/HL/NHLBI NIH HHS; HL-57244/HL/NHLBI NIH HHS; HL-75316/HL/NHLBI NIH HHS; R01 HL075316-07/HL/NHLBI NIH HHS |
| Chemical | |
Reg. No./Substance:
|
0/Fas Ligand Protein; 0/Lysosomal-Associated Membrane Protein 1; 0/Qa-SNARE Proteins; 0/Tetanus Toxin; 0/Vasodilator Agents; 0/Vesicle-Associated Membrane Protein 2; 11062-77-4/Superoxides; 58-82-2/Bradykinin; EC 1.6.3.1/NADPH Oxidase |
| Comments/Corrections | |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Pressure-Volume Relation Analysis of mouse Ventricular Function.
Next Document: Heart rate-associated mechanical stress impairs carotid but not cerebral artery compliance in dyslip...